Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocMorris AGCHIX:DOCMZ -5.02%61 Equity-to-Asset is 0.46 as of Jun. 2026, which is 5% above its 10-year median of 0.44. GuruFocus rates CHIX:DOCMZ with a GF Score™ of 61/100 and a GF Value™ of CHF7.03 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 684 Healthcare Providers & Services companies, DocMorris AG ranks worse than 52.34% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. DocMorris AG's Total Stockholders Equity for the quarter that ended in Jun. 2026 was CHF358 Mil. DocMorris AG's Total Assets for the quarter that ended in Jun. 2026 was CHF776 Mil.
Therefore, DocMorris AG's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.46.
The historical rank and industry rank for DocMorris AG's Equity-to-Asset or its related term are showing as below:
CHIX:DOCMz'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32 Med: 0.44 Max: 0.64
Current: 0.46
During the past 13 years, the highest Equity to Asset Ratio of DocMorris AG was 0.64. The lowest was 0.32. And the median was 0.44.
CHIX:DOCMz's Equity-to-Asset is ranked worse than 52.34% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 0.485
vs CHIX:DOCMz: 0.46
DocMorris AG (CHIX:DOCMz) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
DocMorris AG Equity-to-Asset Related Terms
DocMorris AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Equity-to-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
DocMorris AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (CHIX:DOCMZ) has a Equity-to-Asset of 0.46 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DocMorris AG and its competitors. This is near median its historical median of 0.44. Over the past decade, DocMorris AG's Equity-to-Asset has ranged from 0.32 to 0.64. According to the industry distribution chart, DocMorris AG ranks #358 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 52.3%.
Is DocMorris AG's Equity-to-Asset too high?
DocMorris AG's current Equity-to-Asset of 0.46 is near median its 10-year median of 0.44. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 0.64. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. DocMorris AG's value of 0.46 is 5.2% below this industry median. Based on the distribution chart, DocMorris AG ranks #358 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DocMorris AG has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Equity-to-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #358 out of 684 companies for Equity-to-Asset. This places DocMorris AG in the lower half of its industry. The industry median Equity-to-Asset is 0.49. DocMorris AG's value of 0.46 is 5.2% below this benchmark. Historically, DocMorris AG's own Equity-to-Asset has ranged from 0.32 to 0.64 over the past decade. While the company's 10-year median is 0.44 vs. the industry median of 0.49, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Equity-to-Asset of 0.46 is 5.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Equity-to-Asset is 0.46, which is near median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (CHIX:DOCMZ) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF7.03, compared to a current price of CHF10.21 — trading 45.2% above its estimated fair value. The current Equity-to-Asset is 0.46, which is near median its 10-year median of 0.44 and 5.2% below the Healthcare Providers & Services industry median of 0.49. DocMorris AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For DocMorris AG (CHIX:DOCMZ), the current Equity-to-Asset is 0.46 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (CHIX:DOCMZ) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be overvalued.
The current stock price of CHF10.21 is trading 45.2% above its estimated GF Value™ of CHF7.03.
GuruFocus considers DocMorris AG to be Significantly Overvalued.
Key valuation signals for CHIX:DOCMZ:
Equity-to-Asset: 0.46 (near median its 10-year median of 0.44)
GF Value™: CHF7.03 vs. price of CHF10.21 (45.2% above fair value)
Industry Position: 5.2% below the Healthcare Providers & Services median (#358 of 684)
No single metric tells the full story. See the CHIX:DOCMZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
61GF Score
Get the complete analysis for CHIX:DOCMZ
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:DOCMZ has been successfully added to your 
